Hong Wang

7PUBLICATIONS
70CO-AUTHORS
Predictive and prognostic markersNeurology and neuromuscular diseasesMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 14, 2026
Adiponectin Fortifies White Matter After Chronic Hypoperfusion-Induced Vascular Dementia.

|Apr 27, 2026
Astrocytic frataxin deficiency drives neurocognitive impairment in sickle cell mice.

|Jul 31, 2025
Sucralose Consumption Ablates Cancer Immunotherapy Response through Microbiome Disruption.

Kristin M Morder, Madison Nguyen, Drew N Wilfahrt

|Jan 25, 2024
Synthetic lethal combination of CHK1 and WEE1 inhibition for treatment of castration-resistant prostate cancer.

Yapeng Chao, Yuzhou Chen, Wenxiao Zheng

|Nov 21, 2023
Synthetic lethal combination of CHK1 and WEE1 inhibition for treatment of castration-resistant prostate cancer.

Qiming Wang, Yapeng Chao, Yuzhou Chen

|May 02, 2022
Phase IB Study of GITR Agonist Antibody TRX518 Singly and in Combination with Gemcitabine, Pembrolizumab, or Nivolumab in Patients with Advanced Solid Tumors.

Diwakar Davar, Roberta Zappasodi, Hong Wang

Pageof 2

Frequent Collaborators

3 joint publications

Diwakar Davar

2 joint publications

Xiaoming Hu

1 joint publications

John A McCulloch

1 joint publications

Richard R Rodrigues